Patent · US Active

ApoC-II mimetic peptides

US11827690B2 · kind B2 · utility

0Cited by
4References
6Claims
0Family size

Assignees

Inventors

Key dates

Filing dateMar 9, 2021
Grant dateNov 28, 2023
Priority date—
Expiry dateMar 9, 2041

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/42
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The disclosure provides apolipoprotein C-II (apoC-II) mimetic peptides and methods for treating hypertriglyceridemia in a patient with an effective amount of an apoC-II mimetic peptide.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.